10-K Decoder · All companies

Ovid Therapeutics Inc.

OVID · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$7.25M$570K+1,172%
Operating income−$42.4M−$61.9M+31.4%
Net income−$17.4M−$26.4M+34.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026

$Q3 2026Year earlierChange
Revenue$0K$100K−100%
Operating income−$22.4M−$12.5M−79.2%
Net income−$20.8M−$12.2M−70.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Ovid Therapeutics's revenue in FY2025?
$7.25M in FY2025 (Fiscal year ended Dec 31, 2025), +1,172% vs $570K a year earlier, per its 10-K filed Mar 2026.
Was Ovid Therapeutics profitable in FY2025?
No: net income was −$17.4M and operating income −$42.4M in FY2025.
What was Ovid Therapeutics's revenue in Q3 2026?
$0K (−100% vs a year earlier), per its Form 10-Q filed Nov 10, 2026.